Hui Wu

Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial

Yunpeng Yang, Song Qu, Jingao Li et al. · The Lancet Oncology · 2021 · 429 citations

Medicine, Clinical Trials, Immune Checkpoint Inhibitor +8

The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma

Ling‐Long Tang, Yu‐Pei Chen, Chuanben Chen et al. · Cancer Communications · 2021 · 374 citations · Full text

Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Yu‐Pei Chen, Xu Liu, Qin Zhou et al. · The Lancet · 2021 · 217 citations

Oncology, Advanced Nasopharyngeal Carcinoma, Metronomic Therapy +9

Prognostic value of systemic immune-inflammation index in patients with gastric cancer

Kang Wang, Feiyu Diao, Zhijun Ye et al. · Chinese Journal of Cancer · 2017 · 124 citations · Full text

Novel immunological and nutritional-based prognostic index for gastric cancer

Kaiyu Sun, Jianbo Xu, Shuling Chen et al. · World Journal of Gastroenterology · 2015 · 99 citations · Full text